Abstract
In vitro anti-HIV activity of phosphoprothioate α-anomeric oligodeoxynucleotides : J.-L. Imbach, B. Rayner, F. Morvan (Laboratoire de Chimie Bio-Organique, U.A. 488 du CNRS, Université de Montepellier II, Sciences et Techniques du Languedoc, 43095 Montepellier Cedex 5, France), M. Matsukara (Department of Pediatrics, Kumamoto University, Medical School, 1-1-1 Honjo, Kumamoto City, 860 Japan) and J.S. Cohen (Clinical Pharmacology Branch, Clinical Oncology
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
